Director, Corporate Counsel

Position Overview

Bicara Therapeutics is seeking an experienced Director, Corporate Counsel. This position is responsible for a broad array of matters, including partnering with internal and external stakeholders to ensure the Company’s compliance with US securities laws, preparing and coordinating Board of Directors and committee matters, partnering cross‑functionally on equity compensation matters, and providing timely and efficient legal advice across the Company. This role reports to the Chief Legal Officer.

The role is based in our Boston office and follows a hybrid schedule, with three in‑office days each week.

Responsibilities

• Providing advice on the company’s compliance with applicable securities laws and NASDAQ rules and regulations
• Preparing and reviewing all SEC filings, including periodic and current reports, proxy statements and Section 16 reports in collaboration with internal and external accounting and legal teams
• Preparing and coordinating Board of Directors and committee materials and processes
• Providing legal advice on disclosure matters, including investor presentations, press releases, and other corporate internal and external communications
• Working on corporate governance matters, including assisting in the preparation of certain corporate policies and providing training to employees on those policies
• Coordinating stock equity programs in conjunction with the Finance and People Teams
• Preparing, reviewing and negotiating a diverse range of agreements common to the biotechnology industry
• Working closely with departments to provide legal advice as needed
• Providing advice in a wide array of practice areas and special projects as needed
• Keeping current on industry‑related laws and regulations and creating or modifying policies and procedures based on such developments
• Managing and directing outside counsel when outside expertise is needed
• Working collaboratively with company management, colleagues and various business units to support corporate activities
• Providing risk management and mitigation counseling
• Other duties as assigned

Qualifications

Company Overview

Bicara Therapeutics is a clinical‑stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors. Bicara’s lead program, ficerafusp alfa, is a bifunctional antibody that combines two clinically validated targets, an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF‑β). Through this dual‑targeting mechanism, ficerafusp alfa has the potential to exert potent anti‑tumor activity by simultaneously blocking both cancer cell‑intrinsic EGFR survival and proliferation, as well as the immunosuppressive TGF‑β signaling within the tumor microenvironment. Ficerafusp alfa is being developed in head and neck squamous cell carcinoma, where there remains a significant unmet need, as well as other solid tumor types. For more information, please visit www.bicara.com or follow us on or X.

Bicara Therapeutics is an equal opportunity employer and will not discriminate against any employee or applicant on the basis of age, color, disability, gender, national origin, race, religion, sexual orientation, veteran status, or any classification protected by federal, state, or local law.

#J-18808-Ljbffr